Research Press Releases & Articles 46 - 50 of 60
Melbournians Discover Deep Ancestry:genographic Project Swabs Former Afl Players
30th September 2009 -
Views: 1398
Their 'deep ancestry' will be revealed through National Geographic's Genographic Project.a global study which has already involved more than 350,000 people around the world exploring where they came from up to 60,000 years ago.
Vandetanib Phase Ii Trial Shows Significant Improvement Of Progression Free Survival In Patients Wit
13th September 2010 -
Views: 1440
AstraZeneca today announced results from a phase II study evaluating the
investigational drug vandetanib for the treatment of patients with locally
advanced or metastatic papillary or follicular thyroid cancer.
Type 2 Diabetes Patients With Long-standing Disease Achieved Glycaemic Control
27th June 2010 -
Views: 1455
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced results from the first double-blind, placebo-controlled clinical study to evaluate exenatide injection added to insulin glargine, which showed patients with type 2 diabetes achieved glucose targets without weight gain or increasing their risk of hypoglycaemia.
Exenatide Once Weekly Safety And Tolerability Pooled Summary Data Presented At Ada 2010
27th June 2010 -
Views: 1385
These data further support the known safety profile of the exenatide molecule
and are consistent with the previously reported profiles of exenatide once
weekly and BYETTA(R) (exenatide) injection.
Nglyza(tm) (saxagliptin) With Metformin As Initial Combination Therapy Provided 76-week Long-term Gl
27th June 2010 -
Views: 5781
The study results also demonstrated that a higher number of patients were able to achieve the American Diabetes Association recommended HbA1c target of less than 7% with ONGLYZA and metformin as initial combination therapy, compared to monotherapy of either treatment at week 76.
NEWS 
